Study shows breakthrough cases mean Pfizer, Moderna efficacy plummets; craters by double digit percentage; Pfizer at 42% effective

Sharing is Caring!

The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for coronavirus disease 2019 (COVID-19).

Moderna’s vaccine may be best against Delta 

The mRNA vaccine from Pfizer and BioNTech may be less effective than Moderna’s against the Delta variant of the coronavirus, according to two reports posted on medRxiv on Sunday ahead of peer review.

See also  COVID-19 cases spike at Cornell University despite 95% vaccination rate

In a study of more than 50,000 patients in the Mayo Clinic Health System, researchers found the effectiveness of Moderna’s vaccine against infection had dropped to 76% in July — when the Delta variant was predominant — from 86% in early 2021. Over the same period, the effectiveness of the Pfizer/BioNTech vaccine had fallen to 42% from 76%, researchers said.

See also  Clever classification.... Israel: 93% of new cases among unvaccinated or vaccinated over 6 months earlier

While both vaccines remain effective at preventing COVID hospitalization, a Moderna booster shot may be necessary soon for anyone who got the Pfizer or Moderna vaccines earlier this year, said Dr. Venky Soundararajan of Massachusetts data analytics company nference, who led the Mayo study.

www.msn.com/en-ph/health/medical/moderna-may-be-superior-to-pfizer-against-delta-breakthrough-odds-rise-with-time/ar-AAN85Ua

980 views

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.